Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Sales and Divestitures: 2019-2021

Historic Gains from Sales and Divestitures for IDEAYA Biosciences (IDYA) over the last 2 years, with Dec 2021 value amounting to $7,312.

  • IDEAYA Biosciences' Gains from Sales and Divestitures was N/A to $7,312 in Q4 2021 from the same period last year, while for Dec 2021 it was $7,312, marking a year-over-year change of. This contributed to the annual value of $7,312 for FY2021, which is N/A change from last year.
  • Latest data reveals that IDEAYA Biosciences reported Gains from Sales and Divestitures of $7,312 as of FY2021, which was up 50.24% from $4,867 recorded in FY2019.
  • IDEAYA Biosciences' Gains from Sales and Divestitures' 5-year high stood at $7,312 during FY2021, with a 5-year trough of $4,867 in FY2019.
  • Over the past 2 years, IDEAYA Biosciences' median Gains from Sales and Divestitures value was $6,090 (recorded in 2019), while the average stood at $6,090.